lulupedia
ⲙⲉⲧⲣⲉⲙⲛ̀ⲭⲏⲙⲓ 版本暂未收录,当前展示 English 内容。

Collagen

12818 words·9/25/2026·English
0

Collagen is the primary structural protein in the extracellular matrix of various connective tissues in animals. As the most abundant protein in mammals, comprising approximately 25% to 35% of the body's total protein content, it serves as a fundamental scaffold that provides tensile strength, structural integrity, and elasticity to tissues including skin, bones, tendons, ligaments, cartilage, blood vessels, and teeth. The defining feature of collagen is its triple-helical structure, formed by three polypeptide α-chains containing a characteristic repeating sequence of glycine-X-Y, where X and Y are frequently proline and hydroxyproline. This molecular architecture allows collagen to assemble into fibrils, fibers, and networks that mechanically reinforce tissues and interact with cells to regulate adhesion, migration, and differentiation.

Structure and Molecular Organization

The collagen molecule, also known as tropocollagen, is a right-handed super-helix composed of three left-handed polyproline II-type helices wound around a central axis. Each α-chain consists of the repeating tripeptide motif Gly-X-Y. Glycine, the smallest amino acid, occupies every third residue and is essential for the tight packing of the three chains in the crowded center of the triple helix. The X position is often occupied by proline, and the Y position is frequently 4-hydroxyproline. Hydroxyproline, formed by the post-translational hydroxylation of proline, stabilizes the triple helix through hydrogen bonding and by restricting rotation; together with hydroxylysine, it also contributes to intermolecular cross-linking and glycosylation.

The length of the triple-helical domain varies among collagen types. In fibril-forming collagens, the molecule is about 300 nm long and 1.5 nm in diameter. N- and C-terminal non-helical telopeptides flank the triple helix and participate in cross-link formation. Post-translational modifications, including hydroxylation of lysine residues and subsequent glycosylation, further modulate fibril assembly and interaction with other matrix components. Mature collagen fibers exhibit a characteristic 67-nm periodic banding pattern visible under electron microscopy, which arises from the staggered lateral packing of tropocollagen molecules.

Types and Tissue Distribution

At least 28 genetically distinct types of collagen have been identified in vertebrates, each defined by its α-chain composition, molecular structure, and supramolecular organization. They can be broadly grouped into several classes.

Fibril-forming collagens include types I, II, III, V, and XI. Type I collagen is the most widespread and accounts for approximately 90% of total body collagen; it is the main collagen of skin, bone, tendon, ligament, dentin, and cornea. Type II is primarily found in hyaline and elastic cartilage and in the vitreous humor. Type III collagen coexists with type I in extensible tissues such as skin, blood vessels, and internal organs, and forms reticular fibers. Types V and XI are minor components that regulate fibril diameter by co-assembling with types I and II, respectively.

Network-forming collagens are exemplified by type IV collagen, a major constituent of the basement membrane. Its triple helix is interrupted by non-helical segments, allowing it to form a sheet-like network that provides a filtration barrier and scaffold for epithelial and endothelial cells. Type VIII and X collagens are short-chain collagens that form hexagonal networks, with type X being specifically expressed in hypertrophic cartilage during endochondral ossification.

Fibril-associated collagens with interrupted triple helices (FACITs), such as types IX, XII, XIV, and XVI, do not form fibrils themselves but associate with the surface of fibril-forming collagens and modulate their organization and interaction with other matrix macromolecules. Transmembrane collagens, including types XIII, XVII, and XXV, span cell membranes and mediate cell-matrix adhesion and signaling. Other minor classes include anchoring fibrils (type VII), which link the basement membrane to the underlying matrix, and beaded-filament-forming collagens (type VI), which maintain tissue integrity in muscle and adipose tissue.

Biosynthesis and Assembly

Collagen biosynthesis is a complex, multistep process that begins inside the cell and is completed in the extracellular space.

Intracellular events start with transcription of specific collagen genes, which are large and contain numerous exons encoding the triple-helical domains. Pro-α-chains are synthesized on ribosomes and translocated into the rough endoplasmic reticulum, where signal peptides are cleaved. Hydroxylation of proline and lysine residues is catalyzed by prolyl hydroxylase and lysyl hydroxylase, enzymes that require molecular oxygen, ferrous iron, α-ketoglutarate, and ascorbic acid (vitamin C) as a cofactor. Hydroxylation of proline is critical for triple-helix stability at body temperature. Selected hydroxylysine residues are then glycosylated with galactose or glucosylgalactose. Three pro-α-chains align via their C-terminal propeptides and fold into the triple helix in a zipper-like manner from the C- to the N-terminus, forming a soluble procollagen molecule. This folding is facilitated by chaperones such as protein disulfide isomerase. Procollagen is packaged into transport vesicles and secreted into the extracellular space.

Extracellular processing involves cleavage of the N- and C-propeptides by specific metalloproteinases: ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) procollagen N-proteinase and bone morphogenetic protein 1 (BMP-1)/tolloid-like C-proteinase. Removal of the propeptides reduces solubility and triggers spontaneous self-assembly of tropocollagen into fibrils. Covalent cross-linking is subsequently established by lysyl oxidase, which deaminates lysine and hydroxylysine residues to generate aldehyde groups that undergo a series of condensation reactions. These cross-links mature into stable trivalent cross-links such as pyridinolines, contributing to the extraordinary tensile strength of collagen fibers.

Biological Functions

Collagen provides the principal mechanical framework of the body. Its most fundamental function is to resist tensile forces: collagen fibers in tendons and ligaments transmit muscle-generated loads with minimal elongation, while the more loosely organized fibrils in skin and blood vessels allow for distensibility and recoil. In bone, type I collagen forms the organic template upon which hydroxyapatite crystals are deposited, coupling flexibility with compressive resistance.

Beyond its structural role, collagen profoundly influences cell behavior. Through integrin-mediated binding to specific amino acid sequences such as the RGD (arginine-glycine-aspartate) motif, collagen serves as a substrate for cell adhesion, migration, proliferation, and differentiation. During wound healing, collagen acts as a chemotactic agent for fibroblasts and macrophages, and the newly deposited collagen matrix provides a scaffold for tissue regeneration. In development, collagen gradients and boundaries guide organ morphogenesis. Basement membrane type IV collagen and anchoring fibrils (type VII) maintain tissue compartmentalization and dermal-epidermal cohesion, respectively. Collagen fragments released during matrix turnover also act as biologically active cryptic peptides (matricryptins) that can regulate angiogenesis and tumor progression.

Degradation and Turnover

Collagen turnover is tightly regulated by matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). Under physiological conditions, collagen in soft tissues turns over slowly, with half-lives ranging from months to years, whereas certain collagens in bone are remodeled more rapidly. MMPs, including collagenases (MMP-1, MMP-8, MMP-13) and gelatinases (MMP-2, MMP-9), cleave the triple helix at specific sites once the molecule has been locally unwound. Fragments are further degraded to gelatin and small peptides, which can be endocytosed and fully digested by lysosomal enzymes.

Imbalances in this proteolytic system lead to pathological matrix destruction, as seen in rheumatoid arthritis, periodontitis, and tumor invasion, or to excessive matrix accumulation, as in organ fibrosis. The urinary excretion of collagen cross-links such as pyridinoline and deoxypyridinoline, as well as serum levels of type-specific propeptides and telopeptides, are used clinically as biomarkers of bone resorption and turnover.

Clinical and Medical Applications

Collagen-based biomaterials are widely used in medicine and surgery. Because of its low immunogenicity, bioactivity, and biodegradability, collagen extracted from bovine, porcine, or marine sources, or produced recombinantly, is fabricated into a variety of forms.

In wound care, collagen dressings create a moist environment, absorb exudate, and provide a substrate for cell ingrowth, accelerating granulation tissue formation. In tissue engineering, collagen sponges, hydrogels, and electrospun fibers serve as scaffolds for regenerating skin, cartilage, bone, periodontal ligament, and blood vessels. Injectable collagen has historically been used as a dermal filler for soft-tissue augmentation, though synthetic and autologous alternatives are now more common due to longevity and hypersensitivity concerns. Collagen films and coatings are employed in ophthalmology (corneal shields), neurosurgery (dural substitutes), and as drug-delivery vehicles for sustained release of growth factors and antibiotics.

Collagen is also a key component of surgical sutures and hemostatic agents. In the food and pharmaceutical industries, hydrolyzed collagen (gelatin) is used to produce capsules, stabilizers, and emulsifiers. The clinical use of oral collagen peptides is discussed under dietary supplementation.

Dietary and Cosmetic Use

Hydrolyzed collagen, or collagen peptides, has become a popular nutritional supplement promoted for supporting skin health, reducing joint pain, and strengthening hair and nails. These peptides are produced by enzymatic hydrolysis of native collagen, resulting in low-molecular-weight fragments that are more readily absorbed in the small intestine. A number of randomized, double-blind, placebo-controlled trials have reported improvements in skin hydration, elasticity, and wrinkle depth following daily oral intake of specific collagen peptides over periods of 4 to 12 weeks. Proposed mechanisms include the stimulation of dermal fibroblasts to synthesize new collagen and hyaluronic acid, partially through the provision of proline and hydroxyproline as building blocks and partially through signaling effects of bioactive di- and tripeptides.

Evidence for joint health is also accumulating: some studies indicate that collagen hydrolysates reduce symptoms of osteoarthritis and exercise-induced joint discomfort, though effect sizes are often modest and larger, long-term trials are needed for definitive conclusions. In the cosmetic industry, topical formulations containing collagen are marketed for moisturizing and anti-aging effects. However, intact collagen molecules are too large to penetrate the stratum corneum, so any beneficial effects are mainly attributed to the humectant properties of hydrolyzed collagen or to fragments that may signal surface skin cells. The use of collagen supplements is generally considered safe, with few adverse effects reported besides mild gastrointestinal complaints.

Collagen-Related Disorders

Genetic defects in collagen biosynthesis and structure lead to a diverse group of conditions termed collagenopathies.

Osteogenesis imperfecta, often referred to as brittle bone disease, is most commonly caused by mutations in the genes encoding the α1 or α2 chains of type I collagen. It is characterized by bone fragility, short stature, blue sclerae, hearing loss, and dentinogenesis imperfecta. Severity ranges from a mild form with near-normal lifespan to lethal perinatal types resulting from severe structural defects in the triple helix.

Ehlers-Danlos syndromes represent a heterogeneous group of heritable connective tissue disorders. The classical type involves type V collagen mutations and features skin hyperextensibility, atrophic scarring, and joint hypermobility. The vascular type, caused by mutations in type III collagen, is particularly dangerous due to a propensity for arterial, intestinal, and uterine rupture. Other subtypes involve defects in collagen-processing enzymes, such as lysyl hydroxylase deficiency (kyphoscoliotic type) or ADAMTS2 deficiency (dermatosparaxis type).

Scurvy is an acquired collagen disorder resulting from vitamin C deficiency. Without adequate ascorbic acid, prolyl hydroxylase and lysyl hydroxylase cannot catalyze the hydroxylation of proline and lysine, leading to synthesis of unstable collagen that is poorly secreted, causing capillary fragility, poor wound healing, gingival bleeding, and subperiosteal hemorrhages.

Additional disorders include Alport syndrome (mutations in type IV collagen α-chains, causing progressive kidney disease and hearing loss), dystrophic epidermolysis bullosa (type VII collagen defects, leading to severe skin blistering), and Stickler syndrome (type II or type XI collagen defects, resulting in ocular, auditory, and skeletal abnormalities). Many of these diseases underscore the non-redundant, tissue-specific functions of distinct collagen types.

Evolution and Comparative Biology

Collagen is an ancient protein, with homologs identified in sponges, cnidarians, and all higher metazoans, indicating its early evolutionary origin in the emergence of multicellularity and organized extracellular matrices. Invertebrates possess fibrillar collagens that share the Gly-X-Y repeat and triple-helical structure, though the chain composition and cross-linking patterns differ. In vertebrates, gene duplication events have expanded the collagen family, allowing functional specialization and the development of complex structures such as mineralized skeletons, multilayered skin, and sophisticated vascular systems. Sponges express a primitive type IV-like collagen that forms a basal lamina-like network, and annelids and echinoderms possess fibrillar collagens incorporated into cuticles and body walls.

The remarkable conservation of the collagen triple helix across over 600 million years of evolution highlights its unique mechanical advantages. Comparative studies of collagen cross-linking biochemistry and fibril architecture continue to inform the design of synthetic biomimetic materials that aim to replicate the strength, toughness, and self-assembly properties of natural collagen.

Comments (0)

U

No comments yet. Be the first to comment!

Related Articles